Platelet Rich Plasm Versus Hyaluronic Acid Injection in Chronic Painful Shoulder
CompletedNot applicableNCT05072899
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Aim of This study is to compare between the effect of ultrasound-guided local injection of Platelet Rich Plasma (PRP)versus Hyaluronic (HA) for the treatment of chronic shoulder pain.
Study details
- Official title
- Platelet Rich Plasm Versus Hyaluronic Acid Injection in Chronic Painful Shoulder: Randomized Comparative Trial
- Conditions
- Interventions
- Procedure: platelet rich plasm
- Procedure: Hyaluronic acid
- Sponsor
- Assiut University
- Start date
- 2019-06-15
- Primary completion
- 2020-12-30
- Sex
- All
- Age range
- from 18 Years to 70 Years
- Results posted
- No results posted in this snapshot
- Countries
- Egypt
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Adult patient age \>18 years. * Patients with chronic shoulder pain more than 6 months not responding to medical treatment or physical therapy. * Frozen shoulder. * Rotator cuff disorders (partial tear). Exclusion Criteria: * Shoulder joint instability or traumatic shoulder pain. * Patients with local infection at the shoulder, systemic infection, or inflammatory disease (e.g., rheumatoid arthritis and hepatitis) * Patients with a history of diabetes mellitus and malignancy (either hematological or non-hematological). * Pregnancy. * Patients on anticoagulant therapy. * Injection of shoulder with corticosteroids in the preceding 6 months.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05072899